These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 3767855)

  • 41. Some N-nitrosamines derived from areca-nut alkaloids.
    IARC Monogr Eval Carcinog Risk Chem Hum; 1985 Sep; 37():263-8. PubMed ID: 3866746
    [No Abstract]   [Full Text] [Related]  

  • 42. [An experimental study on bladder carcinogenesis in dogs by N-butyl-N-(4-hydroxybutyl) nitrosamine (BBN) and its urinary metabolites].
    Morishita S; Hamami G; Kamidono S
    Hinyokika Kiyo; 1989 Jan; 35(1):27-38. PubMed ID: 2729018
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ascorbic acid and the formation of N-nitroso compounds: possible role of ascorbic acid in cancer prevention.
    Kyrtopoulos SA
    Am J Clin Nutr; 1987 May; 45(5 Suppl):1344-50. PubMed ID: 3578122
    [No Abstract]   [Full Text] [Related]  

  • 44. Dietary exposure and urinary excretion of total N-nitroso compounds, nitrosamino acids and volatile nitrosamine in inhabitants of high- and low-risk areas for esophageal cancer in southern China.
    Lin K; Shen W; Shen Z; Wu Y; Lu S
    Int J Cancer; 2002 Nov; 102(3):207-11. PubMed ID: 12397637
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mechanisms by which garlic and allyl sulfur compounds suppress carcinogen bioactivation. Garlic and carcinogenesis.
    Milner JA
    Adv Exp Med Biol; 2001; 492():69-81. PubMed ID: 11480676
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Recent studies on N-nitroso compounds as possible etiological factors in oesophageal cancer.
    Lu SH; Ohshima H; Bartsch H
    IARC Sci Publ; 1984; (57):947-53. PubMed ID: 6533080
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Monitoring endogenous nitrosamine formation in man.
    Ohshima H; Bartsch H
    IARC Sci Publ; 1984; (59):233-46. PubMed ID: 6545281
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tumor induction in a rat model for ureterosigmoidostomy without evidence of nitrosamine formation.
    Kälble T; Tricker AR; Berger M; Amelung F; Waldherr R; Hothorn L; Möhring K; Staehler G
    J Urol; 1991 Sep; 146(3):862-6. PubMed ID: 1714971
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Species variations in the metabolism of N-butyl-N-(4-hydroxybutyl) nitrosamine and related compounds in relation to urinary bladder carcinogenesis.
    Suzuki E; Anjo T; Aoki J; Okada M
    Gan; 1983 Feb; 74(1):60-8. PubMed ID: 6840438
    [TBL] [Abstract][Full Text] [Related]  

  • 50. N-Nitroso compounds and human cancer. A molecular epidemiologic approach.
    Choi BC
    Am J Epidemiol; 1985 May; 121(5):737-43. PubMed ID: 4014165
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Increased urinary nitrosamine excretion in paraplegic patients.
    Tricker AR; Stickler DJ; Chawla JC; Preussmann R
    Carcinogenesis; 1991 May; 12(5):943-6. PubMed ID: 2029761
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Endogenous formation of N-nitroso compounds: a current perspective.
    Tannenbaum SR
    IARC Sci Publ; 1987; (84):292-6. PubMed ID: 3679388
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Urinary N-nitrosamino acids as an index of exposure to N-nitroso compounds.
    Ohshima H; Bartsch H
    IARC Sci Publ; 1988; (89):83-91. PubMed ID: 3198235
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Association of cigarette smoking and nitrosamines with urinary bladder cancer: a review.
    Nomura AM
    Natl Cancer Inst Monogr; 1982; 62():185-90. PubMed ID: 7167187
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Bacterial formation and degradation of a nitrosamine, paranitrosodimethylaniline].
    Hau HC; Jacquet J; Prévot AR
    C R Acad Hebd Seances Acad Sci D; 1973 Feb; 276(9):1507-8. PubMed ID: 4198630
    [No Abstract]   [Full Text] [Related]  

  • 56. Gastric juice N-nitrosamines in health and gastroduodenal disease.
    Reed PI; Smith PL; Haines K; House FR; Walters CL
    Lancet; 1981 Sep; 2(8246):550-2. PubMed ID: 6116002
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Metabolic fate of N-butyl-N-(4-hydroxybutyl)nitrosamine homologs in the rat, in relation to their organotropic carcinogenicity to the urinary bladder.
    Suzuki E; Iiyoshi M; Okada M
    Gan; 1981 Feb; 72(1):113-22. PubMed ID: 7274637
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Carcinogenicity test of two unstaurated derivatives of N-nitrosopiperdine in Sprague-Dawley rats.
    Lijinsky W; Taylor HW
    J Natl Cancer Inst; 1976 Dec; 57(6):1315-7. PubMed ID: 187801
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Induction of lung and exocrine pancreas tumors in F344 rats by tobacco-specific and Areca-derived N-nitrosamines.
    Rivenson A; Hoffmann D; Prokopczyk B; Amin S; Hecht SS
    Cancer Res; 1988 Dec; 48(23):6912-7. PubMed ID: 3180100
    [TBL] [Abstract][Full Text] [Related]  

  • 60. N-nitroso compounds and human cancer: where do we stand?
    Bartsch H
    IARC Sci Publ; 1991; (105):1-10. PubMed ID: 1855828
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.